Intel Surges After Strong Q3 Earnings Beat, But Manufacturing Challenges Remain
Chipmaker posts surprise profit and revenue growth amid AI-driven demand and government-backed investments Intel Corporation (INTC) saw its stock jump ...
Tag: News
Ford Beats Q3 Estimates but Cuts 2025 Outlook Following Supplier Fire
Detroit automaker posts record $50.5 billion in quarterly revenue while revising guidance due to aluminum supply disruption Ford Motor Company ...
Scienture Launches Commercial Sales of Arbli™, the First FDA-Approved Ready-to-Use Losartan Suspension
$256 million U.S. market opportunity drives expansion as company kicks off multi-channel promotional campaign Scienture Holdings (SCNX) announced the official ...
Earnings Season Heats Up as Tesla, Netflix, and Auto Giants Take Center Stage
With 12% of S&P 500 companies already reporting, analysts eye 8.5% EPS growth — signaling steady but slowing momentum Earnings ...
Tesla’s Record Revenue Tops Forecasts
Tesla reported record third-quarter revenue, beating Wall Street estimates on Wednesday The electric vehicle maker reported total revenue of $28.1 ...
Beyond Meat’s (BYND) Rocky Road: Near-Term Opportunity or Caution Ahead?
From deep financial stress to meme-stock mania — what comes next for the plant-based company Beyond Meat (BYND) is again ...
Netflix Shares Slide After Q3 Earnings Miss Analyst Expectations
Slight shortfall in revenue and profit sparks 8% stock drop despite year-over-year growth Netflix (NFLX) shares tumbled more than 8% ...
Gold Suffers Sharpest One-Day Drop in Over a Decade as Rally Pauses
Easing trade tensions and a stronger dollar trigger 5.5% plunge, but analysts call it a “bump in the road” for ...
Bitcoin Reclaims $110,000 as Crypto Stocks Surge in Market Rebound
Institutional demand, regulatory momentum, and AI-linked mining boost revive optimism across digital assets itcoin (BTC-USD) climbed back above the $110,000 ...
Replimune Reports Promising New Data for Acral Melanoma Treatment at ESMO 2025
RP1 combined with nivolumab shows meaningful tumor response in rare and aggressive skin cancer Replimune Group (REPL), a clinical-stage biotechnology ...
